Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 -0.53 (-1.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Non Operating Investment Income (2010)

Updated

Celldex Therapeutics (CLDX) recorded Non Operating Investment Income of $50,000 in FY2011, unchanged from $50,000 in FY2010.

Analysis

Celldex Therapeutics (CLDX) Non Operating Investment Income (2010) Analysis & Trends

  • Per Business Quant data, CLDX's Non Operating Investment Income was $50,000 in FY2010 (-91.7%) and $604,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Celldex Therapeutics 2.48 Bn 2.48 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 50,000.00
API Access

Celldex Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CLDX&period=max&api_key=YOUR_API_KEY